Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Toxicity of sup 241 Am in male C57BL mice: relative risk versus sup 226 Ra

Journal Article · · Radiation Research; (USA)
DOI:https://doi.org/10.2307/3577818· OSTI ID:5543451
; ;  [1]
  1. Department of Radioprotection, S.C.K./C.E.N., Mol, (Belgium)

A life-span study on male C57BL mice after injection of various doses of{sup 241}Am was conducted. The effects on life span were evaluated and the incidence of tumors was determined by procedures that take competing risks into account. Bone tumors were induced in the mice by injections of 22 and 58 Bq {sup 241}Am per g. The mice died early from nonneoplastic diseases at the higher dose levels (190, 373, and 1197 Bq {sup 241}Am/g). Additionally, spontaneously occurring tumors such as liver carcinomas, lymphosarcomas, and lymphoreticulosarcomas occurred at an enhanced rate with increasing dose level. The data for survival time after {sup 241}Am injection and death with bone tumor were compared to data collected previously for {sup 226}Ra-injected mice of the same C57BL strain. This enabled direct comparison in the same strain of the effects of the bone-surface seeker {sup 241}Am to the effects of the bone-volume seeker {sup 226}Ra. The proportional hazards model was applied and the rate of death with bone tumor was 12.9 +/- 5.2 times higher after {sup 241}Am injection than after {sup 226}Ra injection if the regression covariate was the average dose to the skeleton. The relative risk was 3.5 +/- 1.7 if regressed on the injected radioactivity. The mortality rate after {sup 241}Am injection was 20.4 +/- 3.6 times higher than after {sup 226}Ra injection if regressed on average dose to the skeleton.

OSTI ID:
5543451
Journal Information:
Radiation Research; (USA), Journal Name: Radiation Research; (USA) Vol. 126:2; ISSN RAREA; ISSN 0033-7587
Country of Publication:
United States
Language:
English